파라아미노페놀 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of para aminophenol Market

The global para aminophenol market was valued at USD 620.6 million in 2025 and is projected to grow to USD 657.3 million in 2026, reaching USD 1,052.9 million by 2034, representing a CAGR of 6.1% during the forecast period. Asia Pacific dominates the market, accounting for 71.6% of the global share in 2025.

Para aminophenol, an organic compound usually available in powder form, is slightly hydrophilic and moderately soluble in water. Its primary applications include the production of paracetamol, a widely used analgesic and antipyretic, as well as in black-and-white film development, dyes, and other coloring products.

The onset of the COVID-19 pandemic significantly impacted the chemical industry. During the early stages of the pandemic, a shortage of para aminophenol occurred due to its critical role in paracetamol production. The increased demand for paracetamol during COVID-19 treatment caused a surge in para aminophenol prices, highlighting its strategic importance in the pharmaceutical supply chain.

Market Size & Forecast

Year Market Size (USD Million) Notes

2025 696.3 Base year market value

2026 737.6 Market growth begins post-COVID recovery

2034 1,184.4 Forecasted market value

Market Share by Region: Asia Pacific dominated with USD 498.6 million in 2025, projected to rise to USD 529.5 million in 2026. North America and Europe accounted for 14.3% and 11.5%, respectively.

Key Country Highlights:

• China: High demand from dyes and intermediates segment (26% share in 2023).
• India: Growth driven by expanding pharmaceutical and cosmetics industries.
• U.S. & Europe: Growth fueled by ageing populations and strong paracetamol demand.

Market Trends

Rising Self-Medication Trends Create Opportunities:

There has been a notable increase in self-medication globally, driving demand for paracetamol. The ease of availability and administration of paracetamol encourages its consumption as a self-medication drug, positively impacting para aminophenol demand. Additionally, rising consumer expenditure on cosmetics, particularly in developing economies, supports the growth of the dyes and intermediates segment.

Market Growth Factors

Expanding Pharmaceutical and Cosmetics Industries:

• Pharmaceuticals: Para aminophenol is a key raw material in manufacturing paracetamol and other drugs like ambroxol, acebutolol, gefitinib, and sorafenib. The pandemic-driven surge in paracetamol demand is expected to sustain market growth.
• Cosmetics: Used in permanent oxidative hair dyes, depigmentation agents, and other formulations, the rising expenditure on cosmetic products fuels market expansion.

Restraining Factors

Environmental and Safety Concerns:

Strict environmental regulations and concerns regarding adverse reactions of para aminophenol-derived drugs, along with growing consumer preference for sustainable cosmetic products, may limit market growth.

Market Segmentation

By End-Use Industry:

• Pharmaceuticals: Largest share, 64.45% in 2026, due to rising paracetamol demand.
• Dyes & Intermediates: Holds 27.2% share in 2023, expected to grow with rising demand for dyes in cosmetics.
• Other Uses: Includes black-and-white film production, pesticide manufacturing, and chemical intermediates.

Regional Insights

• Asia Pacific: Market size USD 498.6 million in 2025, projected to USD 529.5 million in 2026. Major markets: Japan (USD 88.8 million in 2026), China (USD 205.7 million), India (USD 95.5 million). Growth driven by pharmaceuticals, cosmetics, agriculture, and textile industries.
• North America: Market size USD 99.8 million in 2025, projected to USD 105 million in 2026. U.S. market projected at USD 83.8 million in 2026. Growth supported by ageing population and R&D investment.
• Europe: Market USD 79.9 million in 2025, projected to USD 84.2 million in 2026. Key markets: Germany (USD 29.8 million) and UK (USD 14.9 million). Regulatory oversight and mature pharmaceutical industry drive growth.
• Latin America & MEA: Latin America USD 13.5 million in 2025, MEA USD 4.5 million in 2025; modest growth expected due to industrialization and consumer demand.

Key Industry Players

Leading companies focus on expanding production capacities and signing supply agreements with end-users across pharmaceuticals, cosmetics, and textiles. Notable players include:

• Glentham Life Sciences Ltd. (England)
• Wego Chemical Group (U.S.)
• Central Drug House (India)
• Taixing Yangzi Pharm Chemical Co., Ltd. (China)
• Haihang Industry (China)
• Sadhana Nitro Chem Limited (India)

Recent Developments: In June 2022, Sadhana Nitro Chem Limited commenced para aminophenol production at its first plant in India, stabilizing operations and launching products in the domestic pharmaceutical market.

Conclusion

The global para aminophenol market is poised for steady growth, driven primarily by pharmaceutical and cosmetics demand. While environmental and safety regulations may restrain growth, opportunities from rising self-medication trends and expanding industrial applications will support market expansion. Asia Pacific remains the largest market, with North America and Europe exhibiting steady growth, and emerging regions like Latin America and MEA presenting potential opportunities for industry players.

Growth Rate CAGR of 6.1% from 2026-2034

Segmentation By End-use Industry

• Pharmaceutical
• Dyes & Intermediates
• Others

By Geography

• North America (By End-use Industry, By Country)
  • U.S. (By End-use Industry)
  • Canada (By End-use Industry)
• Europe (By End-use Industry, By Country)
  • France (By End-use Industry)
  • Germany (By End-use Industry)
  • U.K. (By End-use Industry)
  • Italy (By End-use Industry)
  • Rest of Europe (By End-use Industry)
• Asia Pacific (By End-use Industry, By Country)
  • China (By End-use Industry)
  • India (By End-use Industry)
  • Japan (By End-use Industry)
  • South Korea (By End-use Industry)
  • Rest of Asia Pacific (By End-use Industry)
• Latin America (By End-use Industry, By Country)
  • Brazil (By End-use Industry)
  • Mexico (By End-use Industry)
  • Rest of Latin America (By End-use Industry)
• Middle East & Africa (By End-use Industry, By Country)
  • GCC (By End-use Industry)
  • South Africa (By End-use Industry)
• Rest of Middle East & Africa (By End-use Industry)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Key Market Trends
• 4.2. Key Developments: Mergers, Acquisition, Partnership, etc.
• 4.3. Latest Technological Advancement
• 4.4. Insights on Sustainability
• 4.5. Porters Five Forces Analysis
• 4.6. Impact of COVID-19 on the Market

5. Global Para Aminophenol Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. By End-use Industry (Volume/Value)
  • 5.2.1. Pharmaceutical
  • 5.2.2. Dyes & Intermediates
  • 5.2.3. Others
• 5.3. By Region (Volume/Value)
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Para Aminophenol Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. By End-use Industry (Volume/Value)
  • 6.2.1. Pharmaceutical
  • 6.2.2. Dyes & Intermediates
  • 6.2.3. Others
• 6.3. By Country (Volume/Value)
  • 6.3.1. U.S.
    • 6.3.1.1. By End-use Industry (Volume/Value)
      • 6.3.1.1.1. Pharmaceutical
      • 6.3.1.1.2. Dyes & Intermediates
      • 6.3.1.1.3. Others
  • 6.3.2. Canada
    • 6.3.2.1. By End-use Industry (Volume/Value)
      • 6.3.2.1.1. Pharmaceutical
      • 6.3.2.1.2. Dyes & Intermediates
      • 6.3.2.1.3. Others

7. Europe Para Aminophenol Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. By End-use Industry (Volume/Value)
  • 7.2.1. Pharmaceutical
  • 7.2.2. Dyes & Intermediates
  • 7.2.3. Others
• 7.3. By Country (Volume/Value)
  • 7.3.1. France
    • 7.3.1.1. By End-use Industry (Volume/Value)
      • 7.3.1.1.1. Pharmaceutical
      • 7.3.1.1.2. Dyes & Intermediates
      • 7.3.1.1.3. Others
  • 7.3.2. Germany
    • 7.3.2.1. By End-use Industry (Volume/Value)
      • 7.3.2.1.1. Pharmaceutical
      • 7.3.2.1.2. Dyes & Intermediates
      • 7.3.2.1.3. Others
  • 7.3.3. U.K.
    • 7.3.3.1. By End-use Industry (Volume/Value)
      • 7.3.3.1.1. Pharmaceutical
      • 7.3.3.1.2. Dyes & Intermediates
      • 7.3.3.1.3. Others
  • 7.3.4. Italy
    • 7.3.4.1. By End-use Industry (Volume/Value)
      • 7.3.4.1.1. Pharmaceutical
      • 7.3.4.1.2. Dyes & Intermediates
      • 7.3.4.1.3. Others
  • 7.3.5. Rest of Europe
    • 7.3.5.1. By End-use Industry (Volume/Value)
      • 7.3.5.1.1. Pharmaceutical
      • 7.3.5.1.2. Dyes & Intermediates
      • 7.3.5.1.3. Others

8. Asia-Pacific Para Aminophenol Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. By End-use Industry (Volume/Value)
  • 8.2.1. Pharmaceutical
  • 8.2.2. Dyes & Intermediates
  • 8.2.3. Others
• 8.3. By Country (Volume/Value)
  • 8.3.1. China
    • 8.3.1.1. By End-use Industry (Volume/Value)
      • 8.3.1.1.1. Pharmaceutical
      • 8.3.1.1.2. Dyes & Intermediates
      • 8.3.1.1.3. Others
  • 8.3.2. India
    • 8.3.2.1. By End-use Industry (Volume/Value)
      • 8.3.2.1.1. Pharmaceutical
      • 8.3.2.1.2. Dyes & Intermediates
      • 8.3.2.1.3. Others
  • 8.3.3. Japan
    • 8.3.3.1. By End-use Industry (Volume/Value)
      • 8.3.3.1.1. Pharmaceutical
      • 8.3.3.1.2. Dyes & Intermediates
      • 8.3.3.1.3. Others
  • 8.3.4. South Korea
    • 8.3.4.1. By End-use Industry (Volume/Value)
      • 8.3.4.1.1. Pharmaceutical
      • 8.3.4.1.2. Dyes & Intermediates
      • 8.3.4.1.3. Others
  • 8.3.5. Rest of Asia Pacific
    • 8.3.5.1. By End-use Industry (Volume/Value)
      • 8.3.5.1.1. Pharmaceutical
      • 8.3.5.1.2. Dyes & Intermediates
      • 8.3.5.1.3. Others

9. Latin America Para Aminophenol Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. By End-use Industry (Volume/Value)
  • 9.2.1. Pharmaceutical
  • 9.2.2. Dyes & Intermediates
  • 9.2.3. Others
• 9.3. By Country (Volume/Value)
  • 9.3.1. Brazil
    • 9.3.1.1. By End-use Industry (Volume/Value)
      • 9.3.1.1.1. Pharmaceutical
      • 9.3.1.1.2. Dyes & Intermediates
      • 9.3.1.1.3. Others
  • 9.3.2. Mexico
    • 9.3.2.1. By End-use Industry (Volume/Value)
      • 9.3.2.1.1. Pharmaceutical
      • 9.3.2.1.2. Dyes & Intermediates
      • 9.3.2.1.3. Others
  • 9.3.3. Rest of Latin America
    • 9.3.3.1. By End-use Industry (Volume/Value)
      • 9.3.3.1.1. Pharmaceutical
      • 9.3.3.1.2. Dyes & Intermediates
      • 9.3.3.1.3. Others

10. Middle East & Africa Para Aminophenol Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. By End-use Industry (Volume/Value)
  • 10.2.1. Pharmaceutical
  • 10.2.2. Dyes & Intermediates
  • 10.2.3. Others
• 10.3. By Country (Volume/Value)
  • 10.3.1. GCC
    • 10.3.1.1. By End-use Industry (Volume/Value)
      • 10.3.1.1.1. Pharmaceutical
      • 10.3.1.1.2. Dyes & Intermediates
      • 10.3.1.1.3. Others
  • 10.3.2. South Africa
    • 10.3.2.1. By End-use Industry (Volume/Value)
      • 10.3.2.1.1. Pharmaceutical
      • 10.3.2.1.2. Dyes & Intermediates
      • 10.3.2.1.3. Others
  • 10.3.3. Rest of Middle East & Africa
    • 10.3.3.1. By End-use Industry (Volume/Value)
      • 10.3.3.1.1. Pharmaceutical
      • 10.3.3.1.2. Dyes & Intermediates
      • 10.3.3.1.3. Others

11. Competitive Landscape

• 11.1. Company Market Share/Ranking Analysis, By Key Players, 2025
• 11.2. Company Profiles
  • 11.2.1. Glentham Life Sciences Ltd.
    • 11.2.1.1. Overview
    • 11.2.1.2. Description
    • 11.2.1.3. Product Portfolio
    • 11.2.1.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.1.5. Recent Developments
  • 11.2.2. Wego Chemical Group
    • 11.2.2.1. Overview
    • 11.2.2.2. Description
    • 11.2.2.3. Product Portfolio
    • 11.2.2.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.2.5. Recent Developments
  • 11.2.3. Central Drug House
    • 11.2.3.1. Overview
    • 11.2.3.2. Description
    • 11.2.3.3. Product Portfolio
    • 11.2.3.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.3.5. Recent Developments
  • 11.2.4. Taixing Yangzi Pharm Chemical Co.,Ltd.
    • 11.2.4.1. Overview
    • 11.2.4.2. Description
    • 11.2.4.3. Product Portfolio
    • 11.2.4.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.4.5. Recent Developments
  • 11.2.5. Haihang Industry
    • 11.2.5.1. Overview
    • 11.2.5.2. Description
    • 11.2.5.3. Product Portfolio
    • 11.2.5.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.5.5. Recent Developments
  • 11.2.6. Hefei TNJ Chemical Industry Co.,Ltd.
    • 11.2.6.1. Overview
    • 11.2.6.2. Description
    • 11.2.6.3. Product Portfolio
    • 11.2.6.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.6.5. Recent Developments
  • 11.2.7. Valiant Organics Ltd.
    • 11.2.7.1. Overview
    • 11.2.7.2. Description
    • 11.2.7.3. Product Portfolio
    • 11.2.7.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.7.5. Recent Developments
  • 11.2.8. SEQENS Group
    • 11.2.8.1. Overview
    • 11.2.8.2. Description
    • 11.2.8.3. Product Portfolio
    • 11.2.8.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.8.5. Recent Developments
  • 11.2.9. Jayvir Dye Chem
    • 11.2.9.1. Overview
    • 11.2.9.2. Description
    • 11.2.9.3. Product Portfolio
    • 11.2.9.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.9.5. Recent Developments
  • 11.2.10. Parachem Fine & Specialty Chemicals
    • 11.2.10.1. Overview
    • 11.2.10.2. Description
    • 11.2.10.3. Product Portfolio
    • 11.2.10.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.10.5. Recent Developments
  • 11.2.11. BHARAT CHEMICALS
    • 11.2.11.1. Overview
    • 11.2.11.2. Description
    • 11.2.11.3. Product Portfolio
    • 11.2.11.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.11.5. Recent Developments
  • 11.2.12. Sadhana Nitro Chem Limited
    • 11.2.12.1. Overview
    • 11.2.12.2. Description
    • 11.2.12.3. Product Portfolio
    • 11.2.12.4. Financials (Data as available in public domain and/or on paid databases)
    • 11.2.12.5. Recent Developments

12. Strategic Recommendations